Target intelligence / Profile preview

Translocated intimin receptor (Tir) (Tir)

Target
Tir
Molecular classification
Bacterial effector protein, Receptor, Virulence factor, Type III secretion system (T3SS) effector
01

Overview

The Translocated intimin receptor (Tir) is a pivotal virulence protein utilized by attaching and effacing (A/E) pathogens, most notably Enteropathogenic Escherichia coli (EPEC) and Enterohemorrhagic Escherichia coli (EHEC) (UniProt: P09151). Unlike traditional host receptors, Tir is produced by the bacterium and injected directly into the host intestinal epithelial cell membrane via a type III secretion system (T3SS) (PMID: 9353126). Once integrated into the host membrane, Tir serves as the specific receptor for the bacterial outer membrane protein, intimin (PMID: 11346795). This Tir-intimin interaction triggers a cascade of host signaling events, including the recruitment of actin-modulating proteins that lead to the formation of actin-rich pedestals beneath the adherent bacteria (PMID: 15123611). These pedestals are essential for stable colonization and the effacement of microvilli, leading to severe diarrheal symptoms and, in the case of EHEC, potential systemic complications like hemolytic uremic syndrome (PMID: 25605758). Given its essential role in pathogenesis and its absence in human biology, Tir represents a highly specific target for anti-infective strategies, including vaccines and small-molecule inhibitors designed to disrupt bacterial adhesion (PMID: 21930754).

Other names
TirEspETranslocated intimin receptor protein
02

Mechanism of action

Blockade of the interaction between the bacterial intimin protein and the host-integrated Tir receptor to prevent stable attachment and pedestal formation (PMID: 11346795).

03

Biological functions

Cell adhesionCytoskeleton reorganizationActin pedestal formationSignal transductionHost-pathogen interaction
04

Disease associations

InfectionDiarrheaHemolytic uremic syndromeGastroenteritis
05

Safety considerations

Potential for off-target effects if inhibitors mimic host proteinsDevelopment of bacterial resistanceChallenges in oral delivery and stability in the gastrointestinal tractImmunogenicity of therapeutic agents
06

Interacting drugs

V510 (investigational vaccine)

2 more in the full profile.

07

Biomarkers

Anti-Tir IgG/IgA antibody titers (PMID: 12117943)Presence of tir gene in clinical isolatesTir protein expression in stool or biopsy samples

Beyond the preview

Go deeper on Translocated intimin receptor (Tir) (Tir).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Translocated intimin receptor (Tir) (Tir).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call